from 30 Jun 2012 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: WINDTREE THERAPEUTICS INC /DE/ quarterly and annual Interest Expense in USD history and change rate from 30 Jun 2012 to 31 Mar 2024.
WINDTREE THERAPEUTICS INC /DE/ Interest Expense for the quarter ending 31 Mar 2024 was $13,000, a 8.3% increase year-over-year.
WINDTREE THERAPEUTICS INC /DE/ Interest Expense for the twelve months ending 31 Mar 2024 was $51,000, a 1.9% decline year-over-year.
WINDTREE THERAPEUTICS INC /DE/ annual Interest Expense for 2023 was $50,000, a 5.7% decline from 2022.
WINDTREE THERAPEUTICS INC /DE/ annual Interest Expense for 2022 was $53,000, a 54% decline from 2021.
WINDTREE THERAPEUTICS INC /DE/ annual Interest Expense for 2021 was $114,000, a 8.8% decline from 2020.
Source SEC data: View on sec.gov

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Change (%)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Interest Expense (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$51,000	$13,000	+$1,000	+8.3%	01 Jan 2024	31 Mar 2024	10-Q	15 May 2024	2024	Q1
Q4 2023	$50,000	$12,000	-$1,000	-7.7%	01 Oct 2023	31 Dec 2023	10-K	16 Apr 2024	2023	FY
Q3 2023	$51,000	$13,000	-$1,000	-7.1%	01 Jul 2023	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$52,000	$13,000	$0	0%	01 Apr 2023	30 Jun 2023	10-Q	07 Aug 2023	2023	Q2
Q1 2023	$52,000	$12,000	-$1,000	-7.7%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2024	2024	Q1
Q4 2022	$53,000	$13,000	$0	0%	01 Oct 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q3 2022	$53,000	$14,000	$0	0%	01 Jul 2022	30 Sep 2022	10-Q	09 Nov 2023	2023	Q3
Q2 2022	$53,000	$13,000	-$33,000	-72%	01 Apr 2022	30 Jun 2022	10-Q	07 Aug 2023	2023	Q2
Q1 2022	$86,000	$13,000	-$28,000	-68%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q4 2021	$114,000	$13,000	+$9,000	+225%	01 Oct 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q3 2021	$105,000	$14,000	-$32,000	-70%	01 Jul 2021	30 Sep 2021	10-Q	14 Nov 2022	2022	Q3
Q2 2021	$137,000	$46,000	+$15,000	+48%	01 Apr 2021	30 Jun 2021	10-Q	11 Aug 2022	2022	Q2
Q1 2021	$122,000	$41,000	-$3,000	-6.8%	01 Jan 2021	31 Mar 2021	10-Q	05 May 2022	2022	Q1
Q4 2020	$125,000	$4,000	-$133,000	-97%	01 Oct 2020	31 Dec 2020	10-K	31 Mar 2022	2021	FY
Q3 2020	$258,000	$46,000	-$59,000	-56%	01 Jul 2020	30 Sep 2020	10-Q	10 Nov 2021	2021	Q3
Q2 2020	$317,000	$31,000	-$86,000	-74%	01 Apr 2020	30 Jun 2020	10-Q	05 Aug 2021	2021	Q2
Q1 2020	$403,000	$44,000	-$92,000	-68%	01 Jan 2020	31 Mar 2020	10-Q	13 May 2021	2021	Q1
Q4 2019	$495,000	$137,000	-$630,000	-82%	01 Oct 2019	31 Dec 2019	10-K	29 Mar 2021	2020	FY
Q3 2019	$1,125,000	$105,000	-$355,000	-77%	01 Jul 2019	30 Sep 2019	10-Q	16 Nov 2020	2020	Q3
Q2 2019	$1,480,000	$117,000	+$25,000	+27%	01 Apr 2019	30 Jun 2019	10-Q	14 Aug 2020	2020	Q2
Q1 2019	$1,455,000	$136,000	+$46,000	+51%	01 Jan 2019	31 Mar 2019	10-Q	13 May 2020	2020	Q1
Q4 2018	$1,409,000	$767,000	+$782,000		01 Oct 2018	31 Dec 2018	10-K	03 Apr 2020	2019	FY
Q3 2018	$627,000	$460,000	-$192,000	-29%	01 Jul 2018	30 Sep 2018	10-Q	14 Nov 2019	2019	Q3
Q2 2018	$819,000	$92,000	-$523,000	-85%	01 Apr 2018	30 Jun 2018	10-Q	14 Aug 2019	2019	Q2
Q1 2018	$1,342,000	$90,000	-$521,000	-85%	01 Jan 2018	31 Mar 2018	10-Q	20 May 2019	2019	Q1
Q4 2017	$1,863,000	$15,000	-$626,000	-102%	01 Oct 2017	31 Dec 2017	10-K/A	23 Apr 2019	2018	FY
Q3 2017	$2,489,000	$652,000	+$4,000	+0.62%	01 Jul 2017	30 Sep 2017	10-Q	14 Nov 2018	2018	Q3
Q2 2017	$2,485,000	$615,000	-$22,000	-3.5%	01 Apr 2017	30 Jun 2017	10-Q	14 Aug 2018	2018	Q2
Q1 2017	$2,507,000	$611,000	-$11,000	-1.8%	01 Jan 2017	31 Mar 2017	10-Q	21 May 2018	2018	Q1
Q4 2016	$2,518,000	$611,000			01 Oct 2016	31 Dec 2016	10-K	17 Apr 2018	2017	FY
Q3 2016		$648,000	-$847,000	-57%	01 Jul 2016	30 Sep 2016	10-Q	14 Nov 2017	2017	Q3
Q2 2016		$637,000	-$623,000	-49%	01 Apr 2016	30 Jun 2016	10-Q	21 Aug 2017	2017	Q2
Q1 2016		$622,000			01 Jan 2016	31 Mar 2016	10-Q	15 May 2017	2017	Q1
Q3 2015		$1,495,000			01 Jul 2015	30 Sep 2015	10-Q	14 Nov 2016	2016	Q3
Q2 2015		$1,260,000			01 Apr 2015	30 Jun 2015	10-Q	10 Aug 2016	2016	Q2
Q3 2013		$353,000	+$349,000	+8725%	01 Jul 2013	30 Sep 2013	10-Q	12 Nov 2013	2013	Q3
Q2 2013		$343,000	+$339,000	+8475%	01 Apr 2013	30 Jun 2013	10-Q	08 Aug 2013	2013	Q2
Q3 2012		$4,000			01 Jul 2012	30 Sep 2012	10-Q	12 Nov 2013	2013	Q3
Q2 2012		$4,000			01 Apr 2012	30 Jun 2012	10-Q	08 Aug 2013	2013	Q2

WINDTREE THERAPEUTICS INC /DE/ Annual Interest Expense (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$50,000	-$3,000	-5.7%	01 Jan 2023	31 Dec 2023	10-K	16 Apr 2024	2023	FY
2022	$53,000	-$61,000	-54%	01 Jan 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
2021	$114,000	-$11,000	-8.8%	01 Jan 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
2020	$125,000	-$370,000	-75%	01 Jan 2020	31 Dec 2020	10-K	31 Mar 2022	2021	FY
2019	$495,000	-$914,000	-65%	01 Jan 2019	31 Dec 2019	10-K	29 Mar 2021	2020	FY
2018	$1,409,000	-$454,000	-24%	01 Jan 2018	31 Dec 2018	10-K	03 Apr 2020	2019	FY
2017	$1,863,000	-$655,000	-26%	01 Jan 2017	31 Dec 2017	10-K/A	23 Apr 2019	2018	FY
2016	$2,518,000	-$2,065,000	-45%	01 Jan 2016	31 Dec 2016	10-K	17 Apr 2018	2017	FY
2015	$4,583,000			01 Jan 2015	31 Dec 2015	10-K	31 Mar 2017	2016	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.